Gabriele Elbl

Gabriele Elbl currently serves as Vice President, Head of Global Regulatory Affairs & R&D QA at ITM Isotope Technologies Munich SE, a position held since January 2023. Prior experience includes Vice President of Global Regulatory Affairs at Nordic Nanovector ASA from 2019 to November 2022 and a similar role as Vice President, Head of Regulatory Affairs at MorphoSys AG between 2013 and 2018. Gabriele Elbl also held the position of Senior VP Regulatory Affairs and Qualified Person at Wilex AG from 2002 to 2013 and worked as a Scientific Administrator at the European Medicines Agency from 1999 to 2002. Early career experience includes serving as Head of the Pharmaceutical Department at Sanofi from 1995 to 1999. Gabriele Elbl holds a PhD in Pharmacy from Ludwig-Maximilians-Universität München.